Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01581645 · ClinicalTrials.gov registry record · Early Phase 1
Mobilaser Study to Help With People Who Are Having Problems With Their Gait
A Early Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 11
- Enrollment target
NCT01581645: Completed Early Phase 1 study, sponsored by Mayo Clinic.
NCT01581645 is a Early Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01581645, a Early Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
Does use of the Mobilaser reduce freezing of gait (FOG) and stride reduction in patients with Parkinson's disease and Parkinsonism.
Interventions
- DEVICE Mobilaser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01581645
The ClinicalTrials.gov registry entry for NCT01581645 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mobilaser is the first listed.
NCT01581645 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01581645 about?
NCT01581645 is a clinical study titled "Mobilaser Study to Help With People Who Are Having Problems With Their Gait". Does use of the Mobilaser reduce freezing of gait (FOG) and stride reduction in patients with Parkinson's disease and Parkinsonism.
What is the current status of trial NCT01581645?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 11 participants. The study started on 2012-05. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01581645?
The interventions under investigation include: Mobilaser (DEVICE).
Who is sponsoring clinical trial NCT01581645?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.